Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
PERI
Alteogen
★★★★
Alteogen reports 1Q26 consolidated revenue KRW71.6bn, operating profit KRW39.3bn; strong global licensing deals
05/15/2026, 03:44 PM
EXCH
Alteogen
★★★★★
EYZANFY (ALT-L9, Aflibercept Biosimilar) Receives MFDS Marketing Approval
05/15/2026, 07:47 AM
EXCH
Alteogen
★
Alteogen 2026 Q1 Provisional Earnings: Sales -14.5% YoY, Operating Profit +100% QoQ
05/08/2026, 12:53 PM